EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Everolimus Delivery via Lignin Nanoparticles Enhances Antitumor Activity in Hormone Receptor-Positive Breast Cancer

Sofia Gabellone, Chiara Spadazzi, Davide Piccinino, Tiziana Castrignanò iD, Claudia Cocchi, Chiara Calabrese, Giovanni Carotenuto, Alessandro De Vita iD, Natalia Ceccotti Vlas, Giacomo Miserocchi, Silvia Vanni iD, Sofia Dellavalle und 5 weitere

Precision Chemistry · 27.07.2026 · 4 (7) · 950-963

DOI: 10.1021/prechem.5c00290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Chemistry, online erschienen am 23.02.2026. Verfasst von Sofia Gabellone und 16 weiteren Autor:innen. Beteiligte Einrichtung: Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Ital…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NextGenerationEU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mTOR inhibitor everolimus improved progression-free survival in patients with hormone receptor-positive breast cancer resistant to hormone therapy. Despite initial success, everolimus has not yet realized its full therapeutic potential due to its associated toxicities and the development of resistance. Here, we exploited biocompatible lignin nanoparticles to enhance everolimus delivery and the mechanism of action in hormone receptor-positive breast cancer cells. Everolimus was released from the lignin nanoparticles in a concentration-dependent manner, following a Fickian diffusion-like model. The nanoparticles protected the drug from potential pH-induced degradation. Confocal microscopy confirmed the diffusion and cytoplasmic localization of lignin nanoparticles, as well as the efficient release of the drug. Everolimus release effectively inhibits the proliferation in breast cancer MCF7 cells. EVE/LNPs showed an improved in vitro antitumor effect compared to EVE against the MCF7 cell line (63 vs 81% survival rate at 10 nM). Under acidic pH conditions, the lignin nanoparticles underwent partial degradation, probably generating oligomers with potential modulating effects on mTOR and FOXM1. Molecular docking simulations showed that lignin oligomers could selectively interact with the ATP-binding cavity of mTOR. The affinity of these interactions was modulated by the redox state of the lignin oligomers, with the strongest bond being observed for quinone derivatives. This dual-action mechanism, which combines drug delivery and modulation of cellular signaling, offers a promising “on/off” switch approach to enhance everolimus-based cancer therapies. Further in vivo studies are warranted to validate these findings.

Schlagwörter

Stichwörter der Autor:innen

FOXM1drug deliveryeverolimuslignin nanoparticlesmTOR

Autor:innen und Institutionen

  • Preclinic and Osteoncology Unit, Biosciences Laboratory, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", 47014 Meldola, Italy.
  • Centro Integrato di Ateneo, Sezione Centro Grandi Attrezzature, Università degli Studi della Tuscia, Largo dell'Università s.n.c., 01100 Viterbo, Italy.
  • Dipartimento di Scienze Ecologiche e Biologiche, Università degli Studi della Tuscia, 01100 Viterbo, Italy.
  • IDI Farmaceutici, Pomezia 00071, Italy.

ORCID-Profile: Tiziana Castrignanò, Alessandro De Vita, Silvia Vanni

Förderung

  • NextGenerationEU

Zitieren

APA

Gabellone, S., Spadazzi, C., Piccinino, D., Castrignanò, T., Cocchi, C., Calabrese, C., Carotenuto, G., De Vita, A., Ceccotti Vlas, N., Miserocchi, G., Vanni, S., Dellavalle, S., Cani, O., Sbanchi, G., Avitabile, D., Liverani, C., & Saladino, R. (2026). Everolimus Delivery via Lignin Nanoparticles Enhances Antitumor Activity in Hormone Receptor-Positive Breast Cancer. Precision Chemistry, 4(7), 950-963. https://doi.org/10.1021/prechem.5c00290

Vancouver

Gabellone S, Spadazzi C, Piccinino D, Castrignanò T, Cocchi C, Calabrese C, et al. Everolimus Delivery via Lignin Nanoparticles Enhances Antitumor Activity in Hormone Receptor-Positive Breast Cancer. Precision Chemistry. 2026;4(7):950-963. doi:10.1021/prechem.5c00290

BibTeX
@article{Gabellone2026,
  author = {Gabellone, Sofia and Spadazzi, Chiara and Piccinino, Davide and Castrignanò, Tiziana and Cocchi, Claudia and Calabrese, Chiara and Carotenuto, Giovanni and De Vita, Alessandro and Ceccotti Vlas, Natalia and Miserocchi, Giacomo and Vanni, Silvia and Dellavalle, Sofia and Cani, Oneda and Sbanchi, Giulia and Avitabile, Daniele and Liverani, Chiara and Saladino, Raffaele},
  title = {Everolimus Delivery via Lignin Nanoparticles Enhances Antitumor Activity in Hormone Receptor-Positive Breast Cancer},
  journal = {Precision Chemistry},
  year = {2026},
  volume = {4},
  number = {7},
  pages = {950--963},
  doi = {10.1021/prechem.5c00290}
}
Kostenlos starten →